Pharma Industry News

Medical News Today: Could an existing drug halt Parkinson’s disease?

Written by David Miller

A new Parkinson's study suggests that drugs for treating a rare genetic disorder may be effective in targeting toxic alpha-synuclein clusters in neurons.

A new Parkinson's study suggests that drugs for treating a rare genetic disorder may be effective in targeting toxic alpha-synuclein clusters in neurons.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]